what are the problems with glp 1 GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment glp 1 drugs and vision

( PMID: 25545186 ) Ko JW, Park KD, Lee Y, Lee JH, Hong DK (2020) Eosinophilic panniculitis following the subcutaneous injection of exenatide extended-release

It activates two receptor systems simultaneously: the GLP-1 receptor and the GIP receptor

The team commends Nestl for embracing the GLP-1 phenomenon rather than fearing it

This step is critical in identifying any imbalances that need to be addressed through therapy

In consideration of the reduced compliance of peptide GLP-1 receptor agonists due to subcutaneous injection, oral micromolecular GLP-1 receptor agonists such as orforglipron have already in clinical trials, which can reduce body weight and improve cardiac metabolism in adults with obesity (Wharton et al 2023) (Fig